Keck Medicine researcher leading clinical trial to expand cutting-edge treatment access for depression patients
Since 2005, vagus nerve stimulation (VNS) therapy has been approved by the Food and Drug Administration (FDA) as a safe and effective treatment option for treatment resistant depression. It has been tested in several research studies, including one at … Read More »